Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible <i>Staphylococcus aureus</i> in a Tertiary Care University Hospital

• Main Authors: Atsushi Uda (Author), Kenichiro Onuma (Author), Katsumi Shigemura (Author), Koichi Kitagawa (Author), Yonmin Yan (Author), Kayo Osawa (Author), Ikuko Yano (Author), Takayuki Miyara (Author)
• Format: Book
• Published: MDPI AG, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cefazolin is an essential antibiotic used for treating bacteremia; in particular, it is recommended as a first-line agent for infections caused by methicillin-susceptible <i>Staphylococcus</i><i>aureus</i> (MSSA). In March 2019, problems with a major antibiotic supplier cause...